182 related articles for article (PubMed ID: 31801149)
1. The Efficacy and Safety of Epicutaneous Immunotherapy for Allergic Diseases: A Systematic Review and Meta-Analysis.
Xiong L; Lin J; Luo Y; Chen W; Dai J
Int Arch Allergy Immunol; 2020; 181(3):170-182. PubMed ID: 31801149
[TBL] [Abstract][Full Text] [Related]
2. From Skin to Solution: Exploring Epicutaneous Immunotherapy for Peanut Allergy-A Systematic Review and Meta-Analysis.
Banatwala UESS; Nasir MM; Javed R; Ahmed A; Farhan SA; Ajam A
Clin Rev Allergy Immunol; 2024 Apr; 66(2):125-137. PubMed ID: 38526693
[TBL] [Abstract][Full Text] [Related]
3. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety.
Chu DK; Wood RA; French S; Fiocchi A; Jordana M; Waserman S; Brożek JL; Schünemann HJ
Lancet; 2019 Jun; 393(10187):2222-2232. PubMed ID: 31030987
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.
Fleischer DM; Shreffler WG; Campbell DE; Green TD; Anvari S; Assa'ad A; Bégin P; Beyer K; Bird JA; Brown-Whitehorn T; Byrne A; Chan ES; Cheema A; Chinthrajah S; Chong HJ; Davis CM; Ford LS; Gagnon R; Greenhawt M; Hourihane JO; Jones SM; Kim EH; Lange L; Lanser BJ; Leonard S; Mahler V; Maronna A; Nowak-Wegrzyn A; Oriel RC; O'Sullivan M; Petroni D; Pongracic JA; Prescott SL; Schneider LC; Smith P; Staab D; Sussman G; Wood R; Yang WH; Lambert R; Peillon A; Bois T; Sampson HA
J Allergy Clin Immunol; 2020 Oct; 146(4):863-874. PubMed ID: 32659313
[TBL] [Abstract][Full Text] [Related]
6. Specific allergen immunotherapy for the treatment of atopic eczema.
Tam H; Calderon MA; Manikam L; Nankervis H; García Núñez I; Williams HC; Durham S; Boyle RJ
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008774. PubMed ID: 26871981
[TBL] [Abstract][Full Text] [Related]
7. Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults.
Jones SM; Sicherer SH; Burks AW; Leung DY; Lindblad RW; Dawson P; Henning AK; Berin MC; Chiang D; Vickery BP; Pesek RD; Cho CB; Davidson WF; Plaut M; Sampson HA; Wood RA;
J Allergy Clin Immunol; 2017 Apr; 139(4):1242-1252.e9. PubMed ID: 28091362
[TBL] [Abstract][Full Text] [Related]
8. Skin care interventions in infants for preventing eczema and food allergy.
Kelleher MM; Phillips R; Brown SJ; Cro S; Cornelius V; Carlsen KCL; Skjerven HO; Rehbinder EM; Lowe AJ; Dissanayake E; Shimojo N; Yonezawa K; Ohya Y; Yamamoto-Hanada K; Morita K; Axon E; Cork M; Cooke A; Van Vogt E; Schmitt J; Weidinger S; McClanahan D; Simpson E; Duley L; Askie LM; Williams HC; Boyle RJ
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013534. PubMed ID: 36373988
[TBL] [Abstract][Full Text] [Related]
9. Targeted allergen-specific immunotherapy within the skin improves allergen delivery to induce desensitization to peanut.
Landers JJ; Janczak KW; Shakya AK; Zarnitsyn V; Patel SR; Baker JR; Gill HS; O'Konek JJ
Immunotherapy; 2022 May; 14(7):539-552. PubMed ID: 35196877
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of epicutaneous immunotherapy for food allergy.
Wang J; Sampson HA
Pediatr Allergy Immunol; 2018 Jun; 29(4):341-349. PubMed ID: 29369411
[TBL] [Abstract][Full Text] [Related]
11. Skin care interventions in infants for preventing eczema and food allergy.
Kelleher MM; Cro S; Cornelius V; Lodrup Carlsen KC; Skjerven HO; Rehbinder EM; Lowe AJ; Dissanayake E; Shimojo N; Yonezawa K; Ohya Y; Yamamoto-Hanada K; Morita K; Axon E; Surber C; Cork M; Cooke A; Tran L; Van Vogt E; Schmitt J; Weidinger S; McClanahan D; Simpson E; Duley L; Askie LM; Chalmers JR; Williams HC; Boyle RJ
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013534. PubMed ID: 33545739
[TBL] [Abstract][Full Text] [Related]
12. Allergen-specific oral immunotherapy for peanut allergy.
Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
[TBL] [Abstract][Full Text] [Related]
13. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
14. Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy.
Mondoulet L; Dioszeghy V; Ligouis M; Dhelft V; Dupont C; Benhamou PH
Clin Exp Allergy; 2010 Apr; 40(4):659-67. PubMed ID: 20002446
[TBL] [Abstract][Full Text] [Related]
15. Epicutaneous peanut patch device for the treatment of peanut allergy.
Langlois A; Graham F; Bégin P
Expert Rev Clin Immunol; 2019 May; 15(5):449-460. PubMed ID: 30864861
[TBL] [Abstract][Full Text] [Related]
16. Allergen immunotherapy and/or biologicals for IgE-mediated food allergy: A systematic review and meta-analysis.
de Silva D; Rodríguez Del Río P; de Jong NW; Khaleva E; Singh C; Nowak-Wegrzyn A; Muraro A; Begin P; Pajno G; Fiocchi A; Sanchez A; Jones C; Nilsson C; Bindslev-Jensen C; Wong G; Sampson H; Beyer K; Marchisotto MJ; Fernandez Rivas M; Meyer R; Lau S; Nurmatov U; Roberts G;
Allergy; 2022 Jun; 77(6):1852-1862. PubMed ID: 35001400
[TBL] [Abstract][Full Text] [Related]
17. Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results.
Pongracic JA; Gagnon R; Sussman G; Siri D; Oriel RC; Brown-Whitehorn TF; Green TD; Campbell DE; Anvari S; Berger WE; Bird JA; Chan ES; Cheema A; Chinthrajah RS; Chong HJ; Dowling PJ; Fineman SM; Fleischer DM; Gonzalez-Reyes E; Kim EH; Lanser BJ; MacGinnitie A; Mehta H; Petroni D; Rupp N; Schneider LC; Scurlock AM; Sher LD; Shreffler WG; Sindher SB; Stillerman A; Wood R; Yang WH; Bois T; Sampson HA; Bégin P
J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1864-1873.e10. PubMed ID: 34848381
[TBL] [Abstract][Full Text] [Related]
18. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis.
Nurmatov U; Dhami S; Arasi S; Pajno GB; Fernandez-Rivas M; Muraro A; Roberts G; Akdis C; Alvaro-Lozano M; Beyer K; Bindslev-Jensen C; Burks W; du Toit G; Ebisawa M; Eigenmann P; Knol E; Makela M; Nadeau KC; O'Mahony L; Papadopoulos N; Poulsen LK; Sackesen C; Sampson H; Santos AF; van Ree R; Timmermans F; Sheikh A
Allergy; 2017 Aug; 72(8):1133-1147. PubMed ID: 28058751
[TBL] [Abstract][Full Text] [Related]
19. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
[TBL] [Abstract][Full Text] [Related]
20. Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials.
Senti G; von Moos S; Tay F; Graf N; Johansen P; Kündig TM
Allergy; 2015 Jun; 70(6):707-10. PubMed ID: 25704072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
